Bio-Techne Corp (FRA:TE1)
€ 76.5 1 (1.32%) Market Cap: 11.96 Bil Enterprise Value: 12.28 Bil PE Ratio: 65.48 PB Ratio: 6.45 GF Score: 92/100

Bio-Techne Corp at Cowen HealthCare Conference Transcript

Mar 04, 2020 / 01:00PM GMT
Release Date Price: €44.5 (+1.14%)
Unidentified Analyst

All right. Good morning. I'm [Chris] from the life science tools and diagnostics research team. With me today is Bio-Techne. From Bio-Techne, we have Jim, who is CFO. He's going to go right through a presentation, and we have a breakout session next door.

So with that, let me turn it over to Jim.

James T. Hippel
Bio-Techne Corporation - Senior VP of Finance & CFO

Great. Thank you. Great to be here. Thanks for joining me early this morning. It's our first time our company has been at the Cowen conference. So it's a pleasure to be here.

Of course, our safe harbor statement and forward-looking statements, you can go to our website and read that in detail.

To start with just an overview generally of our company. Bio-Techne is actually a 40-year-old life science tools company, historically known for its reagents portfolio, primarily proteins, antibodies and immunoassays, immunoassay kits. But over the last 6 or 7 years, we've been transforming the company from what was kind of a rather sleepy, privately run public

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot